Viridian Therapeutics, Inc.
VRDN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001590750
In the last 90 days, Viridian Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 214 institutions reported holding it in 13F filings for Q2 2026, worth $2.50B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Viridian Therapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 124
- −3 vs. Q2 2023
- Shares held
- 50.2M
- +4.10M (+8.9%) vs. Q2 2023
- Total value
- $769.9M
- −$325.8M (−29.7%) vs. Q2 2023
- New holders
- 14
- 55 more added
- Sold out
- 17
- 36 more reduced
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VRDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $2.50B |
| Q1 2026 | 225 | $2.21B |
| Q4 2025 | 229 | $3.36B |
| Q3 2025 | 169 | $2.01B |
| Q2 2025 | 171 | $1.32B |
| Q1 2025 | 177 | $1.23B |
| Q4 2024 | 179 | $1.75B |
| Q3 2024 | 165 | $1.98B |
| Q2 2024 | 138 | $906.2M |
| Q1 2024 | 136 | $1.24B |
| Q4 2023 | 132 | $1.31B |
| Q3 2023 | 124 | $769.9M |
| Q2 2023 | 128 | $1.12B |
| Q1 2023 | 135 | $1.10B |
| Q4 2022 | 122 | $1.21B |
| Q3 2022 | 105 | $778.5M |
| Q2 2022 | 84 | $327.7M |
| Q1 2022 | 72 | $460.9M |
| Q4 2021 | 55 | $459.8M |
| Q3 2021 | 39 | $223.7M |
| Q2 2021 | 26 | $109.8M |
| Q1 2021 | 33 | $84.5M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Viridian Therapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Artal Group S.A. | 504,978 | $7.75M | 0.34% | 00.0% | Unchanged |
| Tang Capital Management LLC | 669,125 | $10.3M | 1.45% | −23,800−3.4% | Reduced |
| Kynam Capital Management, LP | 699,681 | $10.7M | 1.78% | −9,817−1.4% | Reduced |
| Geode Capital Management, LLC | 859,095 | $13.2M | 0.00% | −1,762−0.2% | Reduced |
| Marshall Wace, LLP | 962,493 | $14.8M | 0.03% | +311,314+47.8% | Added |
| Perceptive Advisors LLC | 1,011,205 | $15.5M | 0.52% | −765,181−43.1% | Reduced |
| Logos Global Management LP | 1,050,000 | $16.1M | 2.30% | −75,000−6.7% | Reduced |
| Pictet Asset Management Holding SA | 1,066,343 | $16.4M | 0.02% | +1,066,343 | New |
| Octagon Capital Advisors LP | 1,067,143 | $16.4M | 2.88% | +144,143+15.6% | Added |
| Yiheng Capital Management, L.P. | 1,228,534 | $18.8M | 1.70% | 00.0% | Unchanged |
| Fairmount Funds Management LLC | 1,369,623 | $21.0M | 2.53% | 00.0% | Unchanged |
| Millennium Management LLC | 1,380,650 | $21.2M | 0.02% | +42,862+3.2% | Added |
| Polar Capital Holdings Plc | 1,600,000 | $24.5M | 0.18% | 00.0% | Unchanged |
| Vivo Capital, LLC | 1,678,207 | $25.7M | 3.19% | 00.0% | Unchanged |
| Braidwell LP | 1,735,182 | $26.6M | 0.84% | +528,882+43.8% | Added |
| Alliancebernstein L.P. | 1,890,998 | $29.0M | 0.01% | +316,696+20.1% | Added |
| Ra Capital Management, L.P. | 2,007,946 | $30.8M | 0.61% | 00.0% | Unchanged |
| Commodore Capital LP | 2,200,000 | $33.7M | 3.94% | 00.0% | Unchanged |
| Vanguard Group Inc | 2,448,015 | $37.6M | 0.00% | −148,629−5.7% | Reduced |
| State Street Corp | 2,941,690 | $45.1M | 0.00% | +23,321+0.8% | Added |
| Deep Track Capital, LP | 2,963,267 | $45.5M | 1.76% | +1,683,765+131.6% | Added |
| BlackRock Inc. | 2,993,063 | $45.9M | 0.00% | −123,072−3.9% | Reduced |
| VR Adviser, LLC | 3,082,622 | $47.3M | 4.98% | 00.0% | Unchanged |
| Paradigm Biocapital Advisors LP | 3,681,747 | $56.5M | 3.85% | +1,266,491+52.4% | Added |
| Cormorant Asset Management, LP | 0 | $0 | 0.00% | −850,000−100.0% | Sold out |
| Ally Bridge Group (NY) LLC | 0 | $0 | 0.00% | −201,752−100.0% | Sold out |
| Woodline Partners LP | 0 | $0 | 0.00% | −168,060−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −107,318−100.0% | Sold out |
| Driehaus Capital Management LLC | 0 | $0 | 0.00% | −84,019−100.0% | Sold out |
| Moody Aldrich Partners LLC | 0 | $0 | 0.00% | −57,451−100.0% | Sold out |
| Algert Global LLC | 0 | $0 | 0.00% | −37,025−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −36,000−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −34,000−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −21,018−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −13,451−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −13,300−100.0% | Sold out |
| AQR Capital Management LLC | 0 | $0 | 0.00% | −12,005−100.0% | Sold out |
| First Trust Advisors LP | 0 | $0 | 0.00% | −11,992−100.0% | Sold out |
| SEI Investments Co | 0 | $0 | 0.00% | −9,934−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −9,720−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −9,419−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |